Of note, carcinoma areas expressing E-CAD/pAMPK, lacking VIM/GLUT1, were observed in macro-metastases, indicative of luminal differentiation driving MET (Fig. 5f; part of area 5). The gene discussed is SLC2A1; the disease is carcinoma.